Loading…
Sectoral / Thematic · Nippon India Mutual Fund · AMFI code 102431Nippon India Pharma Fund
Disclosed for 84 months, Sep 2019 to Aug 2026.Published as: NIPPON INDIA PHARMA FUND (An Open Ended Equity Scheme Investing In Pharma Sector)
Portfolio value
₹5,688 Cr
up ₹143 Cr vs Aug 2023
- Stocks held
- 30
- unchanged
- Top 10 weight
- 57.7%
- of the portfolio in its ten largest
- Cash & debt
- 3.9%
- cash, money market and debt
- Moves this month
- 0 in · 0 out
- added to 10, trimmed 9
Nippon India Pharma Fund is an active equity fund in the Sectoral / Thematic category from Nippon India Mutual Fund. In September 2023 it disclosed 30 stocks worth ₹5,688 Cr, up ₹143 Cr from Aug 2023. Its largest positions were Sun Pharmaceutical Industries Limited (13.4%), Lupin Limited (7.8%), Cipla Limited (6.3%); the ten largest together made up 57.7% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 78.0% of its equity. Cash and debt stood at 3.9%. Compared with Aug 2023 the fund entered 0 new stocks and exited 0.
Against 226 other Sectoral / Thematic funds
Concentration
78%
Top-10 weight is higher than 78% of peers
Breadth
13%
Holds more stocks than 13% of peers
Cash
60%
Holds more cash than 60% of peers
Holdings in September 2023
Download CSVEvery line the fund disclosed, with the change against Aug 2023. Click a column to sort; click a company to see every fund that owns it.
- Weight
- 13.36%
- Δ weight
- up 0.21 pts
- Value
- ₹760 Cr
- Δ value
- up ₹30.8 Cr
- Status
- Added
- Weight
- 7.83%
- Δ weight
- up 0.30 pts
- Value
- ₹446 Cr
- Δ value
- up ₹27.9 Cr
- Status
- Added
- Weight
- 6.26%
- Δ weight
- down 0.55 pts
- Value
- ₹356 Cr
- Δ value
- down ₹21.4 Cr
- Status
- Trimmed
- Weight
- 5.40%
- Δ weight
- down 0.16 pts
- Value
- ₹307 Cr
- Δ value
- down ₹1.1 Cr
- Status
- Held
- Weight
- 4.64%
- Δ weight
- up 0.10 pts
- Value
- ₹264 Cr
- Δ value
- up ₹12.1 Cr
- Status
- Added
- Weight
- 4.42%
- Δ weight
- down 0.29 pts
- Value
- ₹251 Cr
- Δ value
- down ₹10 Cr
- Status
- Trimmed
- Weight
- 4.16%
- Δ weight
- down 0.34 pts
- Value
- ₹237 Cr
- Δ value
- down ₹13.1 Cr
- Status
- Trimmed
- Weight
- 4.02%
- Δ weight
- up 0.28 pts
- Value
- ₹229 Cr
- Δ value
- up ₹21.1 Cr
- Status
- Added
- Cash, TREPS & receivables
- Weight
- 3.94%
- Δ weight
- up 0.73 pts
- Value
- ₹224 Cr
- Δ value
- up ₹46 Cr
- Status
- Added
- Weight
- 3.90%
- Δ weight
- up 0.16 pts
- Value
- ₹222 Cr
- Δ value
- up ₹14.6 Cr
- Status
- Added
- Weight
- 3.74%
- Δ weight
- up 0.15 pts
- Value
- ₹213 Cr
- Δ value
- up ₹13.4 Cr
- Status
- Added
- Weight
- 3.63%
- Δ weight
- up 0.06 pts
- Value
- ₹206 Cr
- Δ value
- up ₹8.7 Cr
- Status
- Added
- Weight
- 3.46%
- Δ weight
- down 0.15 pts
- Value
- ₹197 Cr
- Δ value
- down ₹3.5 Cr
- Status
- Trimmed
- Weight
- 3.20%
- Δ weight
- down 0.23 pts
- Value
- ₹182 Cr
- Δ value
- down ₹7.9 Cr
- Status
- Trimmed
- Weight
- 3.11%
- Δ weight
- down 0.07 pts
- Value
- ₹177 Cr
- Δ value
- up ₹53 L
- Status
- Held
- Weight
- 3.10%
- Δ weight
- down 0.09 pts
- Value
- ₹176 Cr
- Δ value
- down ₹75 L
- Status
- Held
- Weight
- 3.06%
- Δ weight
- up 0.05 pts
- Value
- ₹174 Cr
- Δ value
- up ₹7 Cr
- Status
- Added
- Weight
- 2.99%
- Δ weight
- down 0.03 pts
- Value
- ₹170 Cr
- Δ value
- up ₹2.4 Cr
- Status
- Added
- Weight
- 2.55%
- Δ weight
- down 0.09 pts
- Value
- ₹145 Cr
- Δ value
- down ₹1.5 Cr
- Status
- Trimmed
- Weight
- 2.09%
- Δ weight
- down <0.01 pts
- Value
- ₹119 Cr
- Δ value
- up ₹2.9 Cr
- Status
- Added
- Weight
- 2.05%
- Δ weight
- up 0.04 pts
- Value
- ₹116 Cr
- Δ value
- up ₹5.2 Cr
- Status
- Added
- Weight
- 1.99%
- Δ weight
- down 0.03 pts
- Value
- ₹113 Cr
- Δ value
- up ₹1.2 Cr
- Status
- Added
- Weight
- 1.76%
- Δ weight
- up 0.05 pts
- Value
- ₹100 Cr
- Δ value
- up ₹5.4 Cr
- Status
- Added
- Weight
- 1.09%
- Δ weight
- up 0.04 pts
- Value
- ₹62.2 Cr
- Δ value
- up ₹4 Cr
- Status
- Added
- Weight
- 0.99%
- Δ weight
- down 0.13 pts
- Value
- ₹56.5 Cr
- Δ value
- down ₹5.6 Cr
- Status
- Trimmed
- Weight
- 0.96%
- Δ weight
- up 0.07 pts
- Value
- ₹54.3 Cr
- Δ value
- up ₹5.5 Cr
- Status
- Added
- Weight
- 0.93%
- Δ weight
- down 0.06 pts
- Value
- ₹53.2 Cr
- Δ value
- down ₹2 Cr
- Status
- Trimmed
- Weight
- 0.49%
- Δ weight
- up 0.03 pts
- Value
- ₹27.9 Cr
- Δ value
- up ₹2.1 Cr
- Status
- Added
- Weight
- 0.42%
- Δ weight
- down 0.04 pts
- Value
- ₹23.9 Cr
- Δ value
- down ₹1.8 Cr
- Status
- Trimmed
- Weight
- 0.25%
- Δ weight
- down <0.01 pts
- Value
- ₹14.3 Cr
- Δ value
- up ₹26 L
- Status
- Added
- Weight
- 0.21%
- Δ weight
- down <0.01 pts
- Value
- ₹11.7 Cr
- Δ value
- up ₹29 L
- Status
- Added
What changed, Aug 2023 to Sep 2023
New New positions (0)
None.
Exited Exited (0)
None.
Added Biggest additions
- Sun Pharmaceutical Industries Limitedup ₹30.8 Cr (+0.21% pts)
- Lupin Limitedup ₹27.9 Cr (+0.30% pts)
- Aurobindo Pharma Limitedup ₹21.1 Cr (+0.28% pts)
- JB Chemicals & Pharmaceuticals Limitedup ₹14.6 Cr (+0.16% pts)
- Apollo Hospitals Enterprise Limited ₹13.4 Cr (+0.15% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Aug 2023, the weight rose most in Pharmaceuticals & Biotechnology (+0.2 pts), and fell most in Retailing (−0.3 pts).
- Pharmaceuticals & Biotechnology77.8% → 78.0%+0.2 pts
- Retailing4.7% → 4.3%−0.3 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Sep 2020 | Sep 2022 | Mar 2023 | Jun 2023 | Aug 2023 | Sep 2023 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 79.0% | 80.0% | 77.0% | 76.8% | 77.8% | 78.0% |
| Healthcare Services | 18.7% | 18.3% | 19.4% | 18.6% | 16.3% | 16.3% |
| Retailing | — | — | 1.9% | 3.1% | 4.7% | 4.3% |
| Pharmaceuticals | 2.3% | 1.3% | 1.4% | 1.2% | 1.1% | 1.1% |
| Healthcare Equipment & Supplies | — | 0.4% | 0.3% | 0.3% | 0.2% | 0.2% |
Allocation in Sep 2023change vs Aug 2023
- Pharmaceuticals & Biotechnology (20)78.0%▲ 0.2 pts
- Healthcare Services (7)16.3%
- Retailing (1)4.3%▼ 0.3 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal.
Cash & debt, Sep 2023
3.9%
▲ 0.7 pts vs Aug 2023
- Cash alone
- 3.9%
- cash and net receivables
- A year earlier
- 0.4%
- Sep 2022 · now ▲ 3.6 pts
- Last 12 months
- 0.4% – 3.9%
- lowest to highest · record 5.9% in May 2021
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.